Intranasal vaccination with a recombinant protein CTA1-DD-RBF protects mice against hRSV infection

Human respiratory syncytial virus (hRSV) infection is a major pediatric health concern worldwide. Despite more than half a century of efforts, there is still no commercially available vaccine. In this study, we constructed and purified the recombinant protein CTA1-DD-RBF composed of a CTA1-DD mucosa...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Hai, Ren, Hu, Zhang, Yan, Cao, Lei, Xu, Wenbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8452643/
https://www.ncbi.nlm.nih.gov/pubmed/34545126
http://dx.doi.org/10.1038/s41598-021-97535-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8452643/
https://www.ncbi.nlm.nih.gov/pubmed/34545126
http://dx.doi.org/10.1038/s41598-021-97535-6

Ejemplares similares